ArticleThe Journal of clinical endocrinology and metabolism2025
Correction to: "Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial".
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.